Safety and Effectiveness of a Sequential Suture and Plug Vascular Closure Devices Technique for Large-Bore Access Closure after Percutaneous Endovascular Aneurysm Repair.


Journal

Journal of vascular and interventional radiology : JVIR
ISSN: 1535-7732
Titre abrégé: J Vasc Interv Radiol
Pays: United States
ID NLM: 9203369

Informations de publication

Date de publication:
07 2023
Historique:
received: 23 08 2022
revised: 15 02 2023
accepted: 18 03 2023
medline: 30 6 2023
pubmed: 1 4 2023
entrez: 31 3 2023
Statut: ppublish

Résumé

To evaluate the safety and effectiveness of sequential sutures and plugged vascular closure devices (VCDs) for large-bore access closure during percutaneous access endovascular aneurysm repair (PEVAR). Data on 16 patients who underwent PEVAR at the authors' center from January 2022 to May 2022 were retrospectively reviewed. The median age was 72 years (interquartile range [IQR], 59-75 years), with a male-to-female ratio of 3:1. All patients received sequential suture and plug VCDs using dual Exoseal after 1 Proglide for access closure. Success was defined as the ability to achieve complete hemostasis and was confirmed by ultrasonography. The patients were followed up for access-related adverse events at 30 and 90 days after the procedure, and the severity was graded according to the Society of Interventional Radiology (SIR) classification. Overall, 24 access sites were included. The median sheath size was 21 F (IQR, 18-23 F). The median hemostasis time was 11.0 minutes (IQR, 9.3-13.0 minutes), the median procedural time was 133.5 minutes (IQR, 102.5-151.0 minutes), and the median length of stay was 5 days (IQR, 4.0-6.8 days). The success rate was 95.8%, and a pseudoaneurysm (SIR Grade 2) developed in 1 patient, which was treated by a percutaneous injection of thrombin. No other access-related adverse events occurred, and the total adverse event rate was 4.2%. Placement of sequential suture and plug VCDs using 1 Proglide and dual Exoseal is a safe and effective method and may be an option for access closure during PEVAR.

Identifiants

pubmed: 37001637
pii: S1051-0443(23)00253-1
doi: 10.1016/j.jvir.2023.03.019
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1143-1148

Informations de copyright

Copyright © 2023 SIR. Published by Elsevier Inc. All rights reserved.

Auteurs

Chen Xu (C)

Department of Vascular Surgery and Intervention, the Affiliated Suzhou Hospital of Nanjing Medical University, Gusu District, Suzhou, People's Republic of China.

Jiang Li (J)

Department of Vascular Surgery and Intervention, the Affiliated Suzhou Hospital of Nanjing Medical University, Gusu District, Suzhou, People's Republic of China.

Jian-Ting Zhao (JT)

Department of Vascular Surgery and Intervention, the Affiliated Suzhou Hospital of Nanjing Medical University, Gusu District, Suzhou, People's Republic of China.

Zhi-Xuan Zhang (ZX)

Department of Vascular Surgery and Intervention, the Affiliated Suzhou Hospital of Nanjing Medical University, Gusu District, Suzhou, People's Republic of China.

Guo-Xiong Xu (GX)

Department of Vascular Surgery and Intervention, the Affiliated Suzhou Hospital of Nanjing Medical University, Gusu District, Suzhou, People's Republic of China.

Yi-Qi Jin (YQ)

Department of Vascular Surgery and Intervention, the Affiliated Suzhou Hospital of Nanjing Medical University, Gusu District, Suzhou, People's Republic of China. Electronic address: jinyiqi2022@163.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH